DE60231613D1 - Neue expressionsvektoren und deren verwendungen - Google Patents

Neue expressionsvektoren und deren verwendungen

Info

Publication number
DE60231613D1
DE60231613D1 DE60231613T DE60231613T DE60231613D1 DE 60231613 D1 DE60231613 D1 DE 60231613D1 DE 60231613 T DE60231613 T DE 60231613T DE 60231613 T DE60231613 T DE 60231613T DE 60231613 D1 DE60231613 D1 DE 60231613D1
Authority
DE
Germany
Prior art keywords
expression vectors
new expression
new
vectors
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231613T
Other languages
English (en)
Inventor
Kai Krohn
Vesna Blazevic
Marja Taehtinen
Mart Ustav
Urve Toots
Andres Maennik
Annamari Ranki
Ene Ustav
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fit Biotech Oy
Original Assignee
Fit Biotech Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20010922A external-priority patent/FI116851B/fi
Application filed by Fit Biotech Oy filed Critical Fit Biotech Oy
Application granted granted Critical
Publication of DE60231613D1 publication Critical patent/DE60231613D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60231613T 2001-05-03 2002-05-03 Neue expressionsvektoren und deren verwendungen Expired - Lifetime DE60231613D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20010922A FI116851B (fi) 2001-05-03 2001-05-03 Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita
US10/138,098 US7498314B2 (en) 2001-05-03 2002-05-03 Expression vectors and uses thereof
PCT/FI2002/000379 WO2002090558A1 (en) 2001-05-03 2002-05-03 Novel expression vectors and uses thereof

Publications (1)

Publication Number Publication Date
DE60231613D1 true DE60231613D1 (de) 2009-04-30

Family

ID=26161168

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231613T Expired - Lifetime DE60231613D1 (de) 2001-05-03 2002-05-03 Neue expressionsvektoren und deren verwendungen

Country Status (23)

Country Link
EP (1) EP1390516B1 (de)
JP (1) JP5016779B2 (de)
CN (1) CN100430482C (de)
AP (1) AP2368A (de)
AT (1) ATE426035T1 (de)
AU (1) AU2002253198B2 (de)
BR (1) BRPI0209416A8 (de)
CA (1) CA2446260C (de)
CZ (1) CZ301691B6 (de)
DE (1) DE60231613D1 (de)
DK (1) DK1390516T3 (de)
EA (1) EA009388B1 (de)
EE (1) EE05691B1 (de)
ES (1) ES2324095T3 (de)
HK (1) HK1063486A1 (de)
HU (1) HU227667B1 (de)
IL (2) IL158730A0 (de)
MX (1) MXPA03009978A (de)
NZ (1) NZ529327A (de)
PL (1) PL206097B1 (de)
SI (1) SI1390516T1 (de)
SK (1) SK287471B6 (de)
WO (1) WO2002090558A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003292280A1 (en) * 2002-12-20 2004-07-14 Strom & Gulliksson Ip Ab Vectors lacking an origin of replication functioning in mammalian cells and expressing growth factors
FI116068B (fi) * 2003-09-15 2005-09-15 Fit Biotech Oyj Plc Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi
WO2005117997A1 (en) * 2004-06-01 2005-12-15 The Ohio State University Ligands having metal binding ability and targeting properties
EP2047861B1 (de) * 2007-10-12 2019-07-31 Institut Pasteur Für wiederholte Verabreichung geeignete lentivirale Gentransfervektoren und deren medizinische Anwendung
BRPI0813194B8 (pt) 2007-08-03 2021-05-25 Centre Nat Rech Scient kit, partículas de vetor lentiviral, composição de vetores plasmídicos, antígeno derivado de hiv-1 quimérico, proteína de envelope de vsv-g, moléculas de ácido nucleico, composição imunogênica e uso de um vetor lentiviral
US9309493B2 (en) * 2009-03-27 2016-04-12 Eidgenoessische Technische Hochschule Zurich Salmonella enterica presenting C. jejuni N-glycan or derivatives thereof
EP2928910B1 (de) 2012-12-06 2019-09-04 PIN Pharma, Inc. Behandlung von entzündungen, autoimmun-, sowie neurodegenerativen erkrankungen mit immunsuppressiven tat-derivierten polypeptiden
CN107344962B (zh) * 2016-05-04 2021-03-02 中国科学院微生物研究所 阻遏蛋白、调控元件组和基因表达调控系统及其构建方法
WO2018185110A1 (en) 2017-04-03 2018-10-11 Fit Biotech Oy Novel expression vectors and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
ATE199570T1 (de) * 1996-08-16 2001-03-15 Medical Res Council Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln

Also Published As

Publication number Publication date
JP5016779B2 (ja) 2012-09-05
DK1390516T3 (da) 2009-07-13
HK1063486A1 (en) 2004-12-31
NZ529327A (en) 2006-01-27
PL206097B1 (pl) 2010-06-30
WO2002090558A1 (en) 2002-11-14
MXPA03009978A (es) 2005-03-07
BRPI0209416A2 (pt) 2004-03-30
WO2002090558A9 (en) 2003-02-06
SK14692003A3 (sk) 2004-07-07
SK287471B6 (sk) 2010-11-08
HUP0304053A3 (en) 2004-10-28
SI1390516T1 (sl) 2009-08-31
EE05691B1 (et) 2013-12-16
EA200301207A1 (ru) 2004-08-26
CZ20033201A3 (en) 2004-05-12
EA009388B1 (ru) 2007-12-28
ATE426035T1 (de) 2009-04-15
CZ301691B6 (cs) 2010-05-26
AP2003002914A0 (en) 2003-12-31
HU227667B1 (en) 2011-11-28
IL158730A (en) 2010-06-16
IL158730A0 (en) 2004-05-12
AP2368A (en) 2012-02-27
CN100430482C (zh) 2008-11-05
PL367126A1 (en) 2005-02-21
CN1529758A (zh) 2004-09-15
EE200300483A (et) 2004-04-15
CA2446260C (en) 2011-06-14
JP2004533247A (ja) 2004-11-04
CA2446260A1 (en) 2002-11-14
EP1390516B1 (de) 2009-03-18
ES2324095T3 (es) 2009-07-30
BRPI0209416A8 (pt) 2018-05-08
EP1390516A1 (de) 2004-02-25
HUP0304053A2 (hu) 2004-03-29
AU2002253198B2 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
DE60207627D1 (de) Überzug und Überzugszusammensetzung
DE60316588D1 (de) Neue lactame und deren verwendungen
DE50112013D1 (de) Deodorantien und antiperspirantien
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DE60123274D1 (de) Pyrrolcarboxamide und pyrrolcarbothioamide und deren agrochemische verwendungen
NO20040246L (no) TACI'er- og BR3-polypeptider og anvendelser derav
ATE470675T1 (de) Immunoglobulinvarianten und deren verwendungen
DE60236696D1 (de) Neue beschichtete Membranen und andere Artikel
DE60212233D1 (de) Zusammengesetzte Farbstoff-Partikel
DE60215046D1 (de) Vernebler und anwendungsverfahren
DE60233192D1 (de) Hydrophobe und lipophobe zusammensetzung
DE60212600D1 (de) Audiocodierung und decodierung
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
DE60229216D1 (de) Mram architektur und system
ATE503487T1 (de) Myostatin-antagonisten und verwendungen davon
NO20040198L (no) Dolastatin 10 derivater
DE50111690D1 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
DE60230245D1 (de) Wabenkonstruktion und deren zusammenbau
DE60225945D1 (de) Textilausrüstungszusammensetzung und deren anwendung
DE60220486D1 (de) Zurückschaltungseinrichtung und Zurückschaltungsverfahren
ATE476500T1 (de) Neue phospholipasen und deren verwendungen
DE602004003809D1 (de) Neue 14- und 15-gliedrige ringverbindungen
ATE426035T1 (de) Neue expressionsvektoren und deren verwendungen
DE60223540D1 (de) Mundschutz und mundschutzfolie
DE60220505D1 (de) Haarwaschmittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition